Our Solutions   Tafero EM Tablets

Tafero EM Tablets

Tafero EM Tablets

*To be consumed as directed by physician.

Therapies:

Anti Virals

Composition:

Tenofovir Alafenamide 25 mg + Emtricitabine 200 mg

About Tafero EM Tablets

Tafero EM Tablets is an antiretroviral combination containing Emtricitabine 200 mg and Tenofovir Alafenamide 25 mg, used in combination with other antiretroviral agents to treat HIV-1 infection. Both components block the reverse transcriptase enzyme that HIV needs to multiply, helping lower viral load and support immune recovery. Though it does not cure HIV, taking the medicine consistently as prescribed supports long-term viral control, reduces the risk of disease progression, and improves overall treatment outcomes.

Tafero EM Tablets

*To be consumed as directed by physician.


Usage Instructions

  • Tafero EM Tablets should be taken exactly as prescribed by your physician, usually once daily, at the same time each day, with or without food.
  • It must always be used together with other antiretroviral medicines as part of a complete HIV treatment regimen, never as a standalone therapy.
  • Do not skip, double, or stop doses without medical advice, as irregular use can lead to drug resistance.
  • Regular blood monitoring is recommended throughout treatment.

    • Benefits and Use

  • Tafero EM Tablets helps control HIV-1 infection by reducing the viral load in the blood, allowing the immune system to recover and function more effectively.
  • As part of a combination antiretroviral regimen, it lowers the risk of HIV-related complications, unprotected infections, and disease progression.
  • Tenofovir Alafenamide helps improve kidney and bone safety, supporting better long-term tolerability for patients on extended antiretroviral therapy.

    • Safety Information

  • Pregnancy
  • Tafero EM Tablets should be used during pregnancy only when your physician considers the expected benefit to outweigh any potential risk. Inform your doctor if you are pregnant, planning to conceive, or become pregnant while receiving treatment.
  • Breastfeeding
  • Speak with your doctor before using Tafero EM Tablets if you are breastfeeding or intend to breastfeed. Your physician will assess whether the benefits of treatment outweigh any potential risks to the infant.
  • Alcohol
  • Alcohol may place additional strain on the liver, particularly in people receiving treatment for chronic Hepatitis B. Limiting or avoiding alcohol during treatment is recommended unless your doctor advises otherwise.
  • Kidney Disorders
  • Patients with kidney impairment should use Tafero EM Tablets under medical supervision, as periodic assessment of kidney health may be required during therapy. Inform your physician about any history of kidney disease before starting treatment.
  • Liver Disorders
  • People with existing liver conditions should take Tafero EM Tablets only as directed by their physician, with regular follow-up when necessary. Do not stop treatment without medical advice, as this may lead to worsening of the underlying liver condition.

    • Ingredients

    Tenofovir Alafenamide 10 mg + Emtricitabine 250 mg

    How to Use

  • Swallow the tablet with sufficient water.
  • Do not crush, split, or chew it.
  • Take it at the same time every day, with or without food, always alongside your other prescribed antiretroviral medicines.
  • If a dose is missed, take it as soon as remembered, but skip it if the next dose is near.

    • Storage Information

    Store below 30°C.